Fast and accurate global clinical trials
From setup to results in weeks, not months. Safe, efficient, and patient-friendly.
Based in Australia, Diagenta AU specializes in early-phase and decentralized trials. Powered by our own PK/PD and clinical safety labs, we deliver fast and reliable outcomes for evidence-based decisions.
Why Australia?
Australia offers one of the world’s most favourable environments for clinical development:
Trials start in 5-6 weeks
43.5% R&D tax rebate
No IND required
FDA/EU compatible data
Fast and inclusive recruitment
Our competencies
-
Pre-clinical
We provide the insights and strategy to shape successful trials from the very beginning.
• Market intelligence & feasibility
• Indication & model selection
• Thoughtful vendor & academic partnerships
• Strategic consulting -
Early Clinical. First in Human
We simplify early-stage execution, from planning to patient enrolment.
• Trial design & site identification
• Regulatory submissions & site management
• Clinical monitoring
• Data management & biostatistics -
Advanced trials
We leverage technology to scale and accelerate global studies.
• Inclusive patient recruitment
• Decentralized trial management
• Point-of-care diagnostics & telemedicine
• e-Documentation & logistics optimization
Technology advantage
DiaBag® platform
Our proprietary DiaBag® mobile diagnostic platform brings hospital-grade capabilities into patients’ homes, which reduces setup time from months to days.
In-home exams with results in 15 minutes
Vitals, ECG, spirometry, imaging, and labs
Fully integrated with EHR/EDC systems (FHIR API)
Stat labs at no additional cost
Easy to deploy, safe, and cost-efficient
Integrated labs
In-house PK/PD and safety labs deliver lightning-fast accurate results with custom assay development and automated analysis.
With operations in Australia, Asia, Thailand, Uzbekistan, the USA, and Europe, Diagenta offers local expertise backed by global reach.
A partner across three continents
Our teams are fully staffed to deliver region-specific advantages, including Australia's unmatched regulatory speed.
Operating across three continents: Australia • United States • Europe
Who we work with
We work with a wide variety of clients across multiple industries.
Biotech and pharma innovators
Medtech and device developers
CROs and academic institutions
State and federal agencies
Patient advocacy groups